Cellebrite DI Ltd. (CLBT) Stock

About Cellebrite DI Ltd.

Cellebrite DI Ltd. is headquartered in IL.

Cellebrite DI Ltd. (CLBT) stock trades at $12.10 with a market capitalization of $3.04B. The stock is valued at a price-to-earnings (P/E) ratio of 47.58, price-to-book of 5.15, price-to-sales of 5.43. Over the past 52 weeks the stock has ranged between $9.58 and $19.98, and currently trades 39.4% below its 52-week high.

On profitability, Cellebrite DI Ltd. generates a return on equity (ROE) of 11.87%, return on capital employed of 8.97%, an operating margin of 12.76%, a net profit margin of 11.43%.

Cellebrite DI Ltd. by the numbers, 2019–2025

Between 2019 and 2025 Cellebrite DI Ltd. reported revenue of $172.0M rising to $476.0M, a change of +176.7% across 7 years. Compounded, revenue has grown 19.5% a year over five years, 20.7% over three, 18.7% over the last twelve months. Net profit rose to $78.0M.

Operating margin went from -0.9% in 2019 to 14.0% in 2025, a gain of 14.9 percentage points. The most recent net margin is 11.43%. On a trailing twelve-month basis to Jun '26, revenue is $514.0M and net profit $58.0M.

Borrowings stand at $23.0M, cash on hand is $429.1M, cash from operations was $169.0M in the latest year, positive in 7 of the last 7.

Return on equity has averaged -48.0% over five years, and was 16.1% in the most recent year.

The share price itself has compounded at 8.1% a year over five years, 24.4% over three, 2.2% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Cellebrite DI Ltd. (CLBT) — frequently asked questions